204 related articles for article (PubMed ID: 24426757)
1. Epigenetic changes in carcinogenesis of gallbladder.
Tewari M; Agarwal A; Mishra RR; Meena RN; Shukla HS
Indian J Surg Oncol; 2013 Dec; 4(4):356-61. PubMed ID: 24426757
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation as an epigenetic regulator of gallbladder cancer: An overview.
Muhammad JS; Khan MR; Ghias K
Int J Surg; 2018 May; 53():178-183. PubMed ID: 29602013
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
Singh TD; Gupta S; Shrivastav BR; Tiwari PK
Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
[TBL] [Abstract][Full Text] [Related]
4. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.
Brägelmann J; Barahona Ponce C; Marcelain K; Roessler S; Goeppert B; Gallegos I; Colombo A; Sanhueza V; Morales E; Rivera MT; de Toro G; Ortega A; Müller B; Gabler F; Scherer D; Waldenberger M; Reischl E; Boekstegers F; Garate-Calderon V; Umu SU; Rounge TB; Popanda O; Lorenzo Bermejo J
Hepatology; 2021 Jun; 73(6):2293-2310. PubMed ID: 33020926
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression.
Bhunia S; Barbhuiya MA; Gupta S; Shrivastava BR; Tiwari PK
Indian J Med Res; 2020 Apr; 151(4):311-318. PubMed ID: 32461394
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
Singh N; Kazim SN; Sultana R; Tiwari D; Borkotoky R; Kakati S; Nath Das N; Kumar Saikia A; Bose S
Free Radic Res; 2019 May; 53(5):473-485. PubMed ID: 31117842
[TBL] [Abstract][Full Text] [Related]
7. Demographic and clinicopathological Profile of Gall Bladder Cancer Patients: Study from a tertiary care center of the Sub-Himalayan region in Indo-Gangetic Belt.
Gupta A; Gupta S; Siddeek RAT; Chennatt JJ; Singla T; Rajput D; Kumar N; Sehrawat A; Kishore S; Gupta M
J Carcinog; 2021; 20():6. PubMed ID: 34321956
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological Study of Gallbladder Cancer Patients from North Indian Gangetic Planes--a High-Volume Centre's Experience.
Gupta S; Kori C; Kumar V; Misra S; Akhtar N
J Gastrointest Cancer; 2016 Mar; 47(1):27-35. PubMed ID: 26585944
[TBL] [Abstract][Full Text] [Related]
9. Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma.
Behera G; Mitra S; Mishra TS; Purkait S
J Gastrointest Cancer; 2021 Sep; 52(3):1029-1034. PubMed ID: 33051796
[TBL] [Abstract][Full Text] [Related]
10. Cholecystectomy in patients with asymptomatic gallstones to prevent gall bladder cancer--the case against.
Kapoor VK
Indian J Gastroenterol; 2006; 25(3):152-4. PubMed ID: 16877831
[TBL] [Abstract][Full Text] [Related]
11. An overview on possible links between aflatoxin B
Costa J; Lima N; Santos C
Mycotoxin Res; 2021 Aug; 37(3):205-214. PubMed ID: 34019215
[TBL] [Abstract][Full Text] [Related]
12. Global epidemiological trends and variations in the burden of gallbladder cancer.
Vuthaluru S; Sharma P; Chowdhury S; Are C
J Surg Oncol; 2023 Nov; 128(6):980-988. PubMed ID: 37818916
[TBL] [Abstract][Full Text] [Related]
13. Need for Prophylactic Cholecystectomy in Silent Gall Stones in North India.
Mathur AV
Indian J Surg Oncol; 2015 Sep; 6(3):251-5. PubMed ID: 27217672
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for gallbladder cancer: a case-control study.
Jain K; Sreenivas V; Velpandian T; Kapil U; Garg PK
Int J Cancer; 2013 Apr; 132(7):1660-6. PubMed ID: 22890893
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with gall bladder cancer in high incidence areas in India: a systematic review protocol.
Dutta EK; Lewis MG; Albert S
BMJ Open; 2022 Mar; 12(3):e056849. PubMed ID: 35232789
[TBL] [Abstract][Full Text] [Related]
16. Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis.
Ono H; Hiraoka N; Lee YS; Woo SM; Lee WJ; Choi IJ; Saito A; Yanagihara K; Kanai Y; Ohnami S; Chiwaki F; Sasaki H; Sakamoto H; Yoshida T; Saeki N
Genes Chromosomes Cancer; 2012 Jan; 51(1):30-41. PubMed ID: 21936014
[TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.
Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A
Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
Xu S; Jiang C; Lin R; Wang X; Hu X; Chen W; Chen X; Chen T
J Exp Clin Cancer Res; 2021 Nov; 40(1):373. PubMed ID: 34823564
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of gallbladder cancer: An update.
Mishra SK; Kumari N; Krishnani N
Mutat Res; 2019 Nov; 816-818():111674. PubMed ID: 31330366
[TBL] [Abstract][Full Text] [Related]
20. Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach.
D'Afonseca V; Arencibia AD; Echeverría-Vega A; Cerpa L; Cayún JP; Varela NM; Salazar M; Quiñones LA
Cancer Inform; 2020; 19():1176935120922154. PubMed ID: 32546937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
